About Paradigm Spine
Paradigm Spine is a company based in New York (United States) founded in 2005 was acquired by RTI Surgical in November 2018. Paradigm Spine has raised $142.15 million across 15 funding rounds from investors including Fifth Third Bancorp, PDL BioPharma and Trevi Health Ventures. The company has 43 employees as of December 31, 2020. Paradigm Spine offers products and services including HPS 2.0, Coflex, CoFix, Fortilink-TC, and DCI. Paradigm Spine operates in a competitive market with competitors including Nevro, ATEC Spine, Vertos Medical, Relievant Medsystems and LimiFlex, among others.
- Headquarter New York, United States
- Employees 43 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paradigm Spine Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$142.15 M (USD)
in 15 rounds
-
Latest Funding Round
$75 M (USD), Debt – Conventional
Dec 18, 2014
-
Investors
Fifth Third Bancorp
& 6 more
-
Employee Count
43
as on Dec 31, 2020
-
Acquired by
RTI Surgical
(Nov 01, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paradigm Spine
Paradigm Spine offers a comprehensive portfolio of products and services, including HPS 2.0, Coflex, CoFix, Fortilink-TC, and DCI.
Provides universal spine stabilization with fusion and dynamic options.
Offers minimally invasive treatment for spinal canal stenosis relief.
Supports segmental stabilization after spinal decompression procedures.
Facilitates bone ingrowth for spinal fusion using titanium technology.
Enables controlled movement for cervical spine stabilization and protection.
Funding Insights of Paradigm Spine
Paradigm Spine has successfully raised a total of $142.15M across 15 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $75 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Paradigm Spine
Paradigm Spine has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Fifth Third Bancorp, PDL BioPharma and Trevi Health Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Praefinium's website is currently under reconstruction.
|
Locked | Locked | Locked |
Investor details for Paradigm Spine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paradigm Spine
Investment portfolio details for Paradigm Spine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paradigm Spine
Detailed financials for Paradigm Spine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paradigm Spine Comparisons
Peer comparison for Paradigm Spine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paradigm Spine
Paradigm Spine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Vertos Medical, Relievant Medsystems and LimiFlex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of high-frequency spinal cord stimulation implants
|
|
| Locked | Locked | Locked |
Treatment solutions for spine disorders are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive treatments for lumbar spinal stenosis are developed.
|
|
| Locked | Locked | Locked |
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain
|
|
| Locked | Locked | Locked |
Spinal implants are developed for treating spinal stenosis.
|
Detailed competitors of Paradigm Spine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paradigm Spine
Complete news archive for Paradigm Spine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paradigm Spine
Paradigm Spine was founded in 2005.
Paradigm Spine is headquartered in New York, United States. It is registered at New York, New York, United States.
Paradigm Spine is a funded company, having raised a total of $142.15M across 15 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Paradigm Spine is 43.
Paradigm Spine was founded in 2005 and is based in New York, United States. Operations focus on the healthcare sector, where stabilization devices are produced for spinal treatments. Non-fusion spinal implant solutions, including the coflex Interlaminar Stabilization device, are offered specifically for lumbar spinal stenosis. Manufacturing activities support medical applications in orthopedics.
Paradigm Spine's top competitors include Nevro, ATEC Spine and Vertos Medical.
Paradigm Spine offers HPS 2.0, Coflex, CoFix, Fortilink-TC, and DCI.
Paradigm Spine has 7 investors. Key investors include Fifth Third Bancorp, PDL BioPharma, Trevi Health Ventures, Praefinium, and HealthCor Partners.